Table 1 Baseline characteristics of the patients.
Parameter | Total cohort | Deceased | Survived | P* |
|---|---|---|---|---|
No of patients | 31 | 9 | 22 | n/a |
Age (years) | 63.3 ± 17.8 | 65.6 ± 9.2 | 62.4 ± 20.5 | 0.756 |
Sex (m/f) | 20/11 | 5/4 | 15/7 | 1.000 |
BMI (kg/m2) | 28.5 ± 5.4 | 26.9 ± 6.3 | 29.1 ± 5.0 | 0.322 |
Pre-existing conditions, N (%) | ||||
Any | 30 (96.8) | 9 (100) | 21 (95.5) | 1.000 |
Obesity/overweight | 10 (32.3)/11 (35.5) | 2 (22.2)/3 (33.3) | 8 (36.4)/8 (36.4) | 0.417 |
Lung disease | 12 (38.7) | 6 (66.7) | 6 (27.3) | 0.068 |
Coronary artery disease | 7 (22.6) | 2 (22.2) | 5 (22.7) | 1.000 |
Cerebrovascular disease | 5 (16..1) | 2 (22.2) | 3 (13.6) | 0.240 |
Peripheral arterial disease | 2 (6.5) | 1 (11.1) | 1 (4.5) | 0.350 |
Congestive heart failure | 4 (12.6) | 1 (11.1) | 3 (13.6) | 1.000 |
Cancer | 7 (19.4) | 2 (22.2) | 5 (22.7) | 1.000 |
Chronic kidney disease | 5 (16.1) | 2 (22.2) | 3 (13.6) | 0.639 |
Diabetes mellitus | 4 (12.9) | 1 (11.1) | 3 (13.6) | 1.000 |
Hypertension | 19 (61.3) | 7 (77.8) | 12 (54.5) | 0.160 |
Current smoking | 4 (12.9) | 1 (11.1) | 3 (13.6) | 1.000 |
Clinical findings at admission, N (%) | ||||
SOFA score | 4.2 ± 4.0 | 7.0 ± 3.8 | 3.0 ± 3.5 | 0.004 |
SaO2 (%) | 91.6 ± 4.6 | 89.5 ± 4.2 | 92.63 ± 4.5 | 0.090 |
Dyspnoea | 16 (51.6) | 6 (66.7) | 10 (45.5) | 0.270 |
Fever | 19 (61.3) | 5 (55.6) | 14 (63.6) | 0.466 |
Cough | 18 (58.1) | 6 (66.7) | 12 (54.5) | 1.000 |
Taste or smell dysfunction | 5 (16.1) | 1 (11.1) | 4 (18.2) | 1.000 |
Fatigue | 11 (35.5) | 2 (22.2) | 9 (40.9) | 0.278 |
Laboratory parameters at admission | ||||
Leukocyte count (1/nL) | 11.4 ± 8.1 | 18.7 ± 11.0 | 8.4 ± 4.0 | 0.003 |
C-reactive protein (mg/L) | 104.6 ± 85.0 | 182.2 ± 93.1 | 75.1 ± 61.4 | 0.003 |
Pro-calcitonin (ng/mL) | 1.81 ± 6.33 | 4.89 ± 10.86 | 0.35 ± 0.82 | < 0.001 |
eGFR (mL/min) | 80.5 ± 28.7 | 68.9 ± 31.6 | 85.3 ± 26.8 | 0.153 |
D-dimers (ng/mL) | 19,711 ± 27,243 | 20,393 ± 21,232 | 18,891 ± 35,922 | 0.242 |
